TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

30.30$ -0.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow PBLS
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – -2,447.3%
– – – 400.7%
– – – 2,455.4%
– – – 25,349.3%
– – – 416.2%
– – – -23,015.5%
– – – -2,639.9%
– – – 537,639.2%
– – – 512,176.4%
– – – -2,863.5%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?